Ly,L.V., M.Sluijter, M.Versluis, G.P.Luyten, M.J.van Stipdonk, S.H.van der Burg, C.J.Melief, M.J.Jager, and T.van Hall. 2010. Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res. 70:8339-8346.

Fransen,M.F., M.J.van Stipdonk, M.Sluijter, S.P.Schoenberger, C.J.Melief, and R.Offringa. 2010. Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation. J. Immunol. 185:3167-3173.

van Stipdonk, M.J., D. Badia-Martinez, M. Sluijter, R. Offringa, T. van Hall, and A. Achour. Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100. 2009. Cancer Res 69:7784-7792.

van Stipdonk, M.J., M. Sluijter, W.G. Han, and R. Offringa. Development of CTL memory despite arrested clonal expansion. 2008. Eur J Immunol. 38:1839-46.

Kel, J.M., E.D. de Geus, M.J. van Stipdonk, J.W. Drijfhout, F. Koning, and L. Nagelkerken. Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. 2008. Int Immunol 20:117-27.

Rahmouni, S., T. Vang, A. Alonso, S. Williams, M. van Stipdonk, C. Soncini, M. Moutschen, S.P. Schoenberger, and T. Mustelin. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein. 2005 Mol Cell Biol 25:2227-41.

van Stipdonk,M.J., G. Hardenberg, M.S. Bijker, E.E. Lemmens, N.M. Droin, D.R. Green, and S.P. Schoenberger. 2003. Dynamic programming of CD8(+) T lymphocyte responses. Nat Immunol 4:361-5.

Alonso,A., S. Rahmouni, S. Williams, M. van Stipdonk, L. Jaroszewski, A. Godzik, R.T. Abraham, S.P. Schoenberger, and T. Mustelin. 2003. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat Immunol 4:44-8.

Homann, D., A. Jahreis, T. Wolfe, A. Hughes, B. Coon, M.J. van Stipdonk, K.R. Prilliman, S.P. Schoenberger, and M.G. von Herrath. 2002. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16:403-15.

Bi, K., Y. Tanaka, N. Coudronniere, K. Sugie, S. Hong, M.J. van Stipdonk, and A. Altman. 2001. Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat Immunol 2:556-63.

Van Stipdonk, M.J., E.E. Lemmens, and S.P. Schoenberger. 2001. Naïve cytotoxic T lymphocytes require a single brief period of antigenic stimulation for expansion and differentiation. Nat Immunol 2:423-9.

Van Stipdonk, M.J., A.A. Willems, R. Verbeek, C.J. Boog, and J.M. van Noort. 2000. T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. Cell Immunol 204:128-34.

Van Stipdonk, M.J., A.A. Willems, A.C. Plomp, J.M. van Noort, and C.J. Boog. 2000. Tolerance controls encephalitogenicity of alphaB-crystallin in the Lewis rat. J Neuroimmunol 103:103-11.

Van Noort, J.M., J.J. Bajramovic, A.C. Plomp, and M.J. van Stipdonk. 2000. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis. J Neuroimmunol 105:46-57.

Thoua, N.M., J.M. van Noort, D. Baker, A. Bose, A.C. van Sechel, M.J. van Stipdonk, P.J. Travers, and S. Amor. 2000. Encephalitogenic and immunogenic potential of the stress protein alphaB- crystallin in Biozzi ABH (H-2A(g7)) mice. J Neuroimmunol 104:47-57.

Van Sechel, A.C., J.J. Bajramovic, M.J. van Stipdonk, C. Persoon-Deen, S.B. Geutskens, and J.M. van Noort. 1999. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 162:129-35.

Van Stipdonk, M.J., A.A. Willems, S. Amor, C. Persoon-Deen, P.J. Travers, C.J. Boog, and J.M. van Noort. 1998. T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. Int Immunol 10:943-50.

Laman, J.D., C.B. Maassen, M.M. Schellekens, L. Visser, M. Kap, E. de Jong, M. van Puijenbroek, M.J. van Stipdonk, M. van Meurs, C. Schwarzler, and U. Gunthert. 1998. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult Scler 4:147-53.

Van Noort, J.M., A.C. van Sechel, M.J. van Stipdonk, and J.J. Bajramovic. 1998. The small heat shock protein alpha B-crystallin as key autoantigen in multiple sclerosis. Prog Brain Res 117:435-52.

Broeren, C.P., M.A. Lucassen, M.J. van Stipdonk, R. van der Zee, C.J. Boog, J.G. Kusters, and W. van Eden. 1994. CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci U S A 91:5997-6001.